AURORA targets a high-unmet-need population: metastatic non-squamous NSCLC with progression on pembrolizumab and platinum ...

FDA authorized Tregzi for adults with acute leukemia, MDS, and other hematologic malignancies receiving closely matched donor ...

Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...

Inclusive leadership is demonstrated through consistent respect, psychological safety, and communication that makes patients ...

Oncology physical therapist Dr. Leslie Waltke demonstrates calf raises, a simple at-home exercise to help rebuild lower body ...

Her proposal to quantify ropeginterferon alfa-2b transport during pregnancy catalyzed cross-disciplinary collaboration and ...

A UF Health oncologist answers the most common questions about cell therapy, from who qualifies to how it differs from ...

A Department of Defense–funded initiative targets underrepresented kidney cancer populations to improve clinical trial participation and address persistent disparities in access to novel therapies.

A cancer survivor shares what happens when a routine surveillance scan brings an unexpected finding — and how she navigated ...

Nicholas Hornstein, MD, PhD discusses ctDNA in colorectal cancer, the INTERCEPT-TT trial, building Northwell's GI oncology program, and what better drugs will look like. In this episode of The ...